Assertio Holdings Inc (ASRT)
1.01
+0.09
(+9.64%)
USD |
NASDAQ |
May 02, 16:00
1.00
-0.01
(-0.99%)
After-Hours: 20:00
Assertio Holdings Total Liabilities (Quarterly): 148.42M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 148.42M |
| September 30, 2023 | 187.16M |
| June 30, 2023 | 150.91M |
| March 31, 2023 | 163.61M |
| December 31, 2022 | 188.19M |
| September 30, 2022 | 188.43M |
| June 30, 2022 | 193.61M |
| March 31, 2022 | 227.27M |
| December 31, 2021 | 224.13M |
| September 30, 2021 | 202.44M |
| June 30, 2021 | 219.75M |
| March 31, 2021 | 220.12M |
| December 31, 2020 | 247.76M |
| September 30, 2020 | 256.85M |
| June 30, 2020 | 260.75M |
| March 31, 2020 | 135.24M |
| December 31, 2019 | 469.21M |
| September 30, 2019 | 508.43M |
| June 30, 2019 | 615.44M |
| March 31, 2019 | 674.92M |
| December 31, 2018 | 712.53M |
| September 30, 2018 | 741.10M |
| June 30, 2018 | 720.99M |
| March 31, 2018 | 795.98M |
| December 31, 2017 | 869.11M |
| Date | Value |
|---|---|
| September 30, 2017 | 860.86M |
| June 30, 2017 | 874.20M |
| March 31, 2017 | 949.51M |
| December 31, 2016 | 974.55M |
| September 30, 2016 | 958.96M |
| June 30, 2016 | 948.98M |
| March 31, 2016 | 1.036B |
| December 31, 2015 | 1.042B |
| September 30, 2015 | 1.021B |
| June 30, 2015 | 976.66M |
| March 31, 2015 | 344.36M |
| December 31, 2014 | 346.62M |
| September 30, 2014 | 478.97M |
| June 30, 2014 | 279.15M |
| March 31, 2014 | 308.36M |
| December 31, 2013 | 371.24M |
| September 30, 2013 | 64.53M |
| June 30, 2013 | 51.05M |
| March 31, 2013 | 54.97M |
| December 31, 2012 | 57.72M |
| September 30, 2012 | 59.27M |
| June 30, 2012 | 57.71M |
| March 31, 2012 | 52.92M |
| December 31, 2011 | 58.45M |
| September 30, 2011 | 53.54M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
135.24M
Minimum
Mar 2020
615.44M
Maximum
Jun 2019
253.04M
Average
219.75M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Ocular Therapeutix Inc | 160.93M |
| Cormedix Inc | 11.92M |
| Verastem Inc | 92.34M |
| Puma Biotechnology Inc | 177.09M |
| CytomX Therapeutics Inc | 249.24M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 286.42M |
| Shareholders Equity (Quarterly) | 138.00M |
| Debt to Equity Ratio | 0.2768 |
| Current Ratio | 1.831 |
| Net Debt Paydown Yield | 5.91% |